Tag: neurostimulation

December 6, 2018

Nuvectra Completes 3,000 U.S. Algovita SCS Implantations

Nuvectra (NASDAQ:NVTR), a neurostimulation medical device company, announced today that the Company’s Algovita Spinal Cord Stimulation (SCS) system has been implanted...
November 1, 2018

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,112,040 titled “Transcutaneous electrical...
April 19, 2018

NeuroMetrix Reports Q1 2018 Financial Results

NeuroMetrix (Nasdaq:NURO) reported financial and business highlights for the quarter ended March 31, 2018. As quoted in the press release:...
April 11, 2018

NeuroMetrix Reports Pain Relief Device Clinical Study Results

Further studies after a product is approved can provide more insight into boosting sales — especially studies involving current medical...
March 7, 2018

Nuvectra Reports Fourth Quarter and Full Year 2017 Financial Results

Nuvectra (NASDAQ:NVTR), a neurostimulation medical device company, announced financial results for the fourth quarter and full year ended December 31,...
February 7, 2018

8 Medical Device Stocks on the TSX and TSXV

Here, the Investing News Network looks at publicly traded medical device and technology companies listed on the TSX.
February 1, 2018

Nuvectra™ Announces Pricing of Follow-On Stock Offering

Nuvectra (NASDAQ:NVTR), a neurostimulation medical device company, announced today the pricing of its underwritten follow-on public offering of 2,825,000 shares...